Cmvgen

FDA 510(k) K974456 · Instrumentation Laboratory CO

Substantially Equivalent

510(k) numberK974456

Submission

Device name
Cmvgen
Applicant
Instrumentation Laboratory CO
Lexington, MA, US
Received
November 25, 1997
Decision date
May 1, 1998
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LJO – Antigen, Iha, Cytomegalovirus
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3175
Specialty
Microbiology

Other 510(k)s with product code LJO

510(k)DeviceApplicantDecision
K203612Capture-CMVLJO · Traditional Immucor, Inc.03/22/2021SE
K183571Capture-CMVLJO · Traditional Immucor, Inc.02/04/2019SE
K001767Diamedix Is-Cmv Igm Capture Test SystemLJO · Traditional Diamedix Corp.08/07/2000SE
K974901Hybrid Capture System CMV DNA AssayLJO · Traditional Digene Corp.09/29/1998SE
K951851Alliance Cytomegalovirus Immediate Early Antigen Direct Immunofluorescence AssayLJO · Traditional E.I. Dupont DE Nemours & Co., Inc.07/24/1996SE
K955799Copalis CMV Total Antibody AssayLJO · Traditional Sienna Biotech, Inc.07/10/1996SE
K920222Healthtest Assay for Antibody to CytomegalovirusLJO · Traditional Akers Research Corp.07/27/1992SE
K910003Cytomegalovirus Antibody ScreenLJO · Traditional Immucor, Inc.03/20/1991SE
K852494Cmv-IhaLJO · Traditional Hillcrest Biologicals09/16/1985SE
K841520CMV Latex Agglutination Test KitLJO · Traditional Bd Becton Dickinson Vacutainer Systems Preanalytic09/07/1984SE

More from Bd Becton Dickinson Vacutainer Systems Preanalytic

510(k)DeviceDecision
K233790Acl Top 970 CLJPA · Special 12/29/2023SE
K230852HemosIL Chromogenic Factor IXGGP · Traditional 12/13/2023SE
K221359ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgMJPA · Traditional 09/29/2023SE
K223608GEM Premier 7000 with IQM3CHL · Traditional 08/10/2023SE
K223187HemosIL Liquid Anti-XaQLU · Traditional 06/23/2023SE
K231031ACL TOP Family 70 SeriesGKP · Traditional 06/21/2023SE
K223090GEM Premier ChemSTATCGA · Special 01/27/2023SE
K223402HemosIL von Willebrand Factor AntigenGGP · Special 12/09/2022SE
K213464HemosIL Liquid Anti-XaKFF · Special 10/04/2022SE
K213426HemosIL ReadiPlasTinGJS · Traditional 08/16/2022SE

Questions and answers

When was Cmvgen cleared by the FDA?

Cmvgen (K974456) received a 510(k) decision of Substantially Equivalent on May 1, 1998, 157 days after the submission was received.

What is the product code of K974456?

The FDA product code is LJO – Antigen, Iha, Cytomegalovirus, a Class II (moderate risk) device regulated under 21 CFR 866.3175.